| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 03/31/2010 | CN101687902A 8-beta-substituted estratrienes as selectively active estrogens |
| 03/30/2010 | US7687486 Selective estrogen receptor modulators |
| 03/25/2010 | US20100076171 polymer obtained by a compound containing a sterol ferulate skeleton; transparency, mechanical strength, coating property, solubility, degree of crystallinity |
| 03/25/2010 | US20100074845 Enhanced sensitivity carbon nanotubes as targeted photoacoustic molecular imaging agents |
| 03/17/2010 | EP1315502B1 Method for treating erectile dysfunction and increasing libido in men |
| 03/16/2010 | CA2287129C Stabilization of biological fluids by addition of sterol esters |
| 03/10/2010 | CN101665526A Synthesis method for 17alpha-estradiol and intermediate compound thereof |
| 03/03/2010 | CN101659686A Method for synthesizing delta 9(11) androstane compound |
| 03/02/2010 | US7671044 Pharmaceutical formula for treating skin disease |
| 02/25/2010 | US20100048887 Compounds including an anti-inflammatory pharmacore and methods of use |
| 02/23/2010 | US7667056 Process and new intermediates for the preparation of steroids with a progestogen activity |
| 02/23/2010 | CA2319916C Use of dhea, its precursors or its metabolic derivatives as a depigmentation agent |
| 02/18/2010 | US20100041906 Method for the precipitation of organic compounds |
| 02/11/2010 | US20100036115 Novel Compositions for the Delivery of Negatively Charged Molecules |
| 02/11/2010 | US20100035793 Modulators |
| 02/10/2010 | EP2150256A1 Locally active "soft" antiandrogens |
| 02/04/2010 | US20100029603 16alpha-methyl or ethyl substituted estrogens |
| 01/26/2010 | CA2505575C 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 01/26/2010 | CA2427632C Process for the production of 4-(17.alpha.-substituted-3-oxoestra-4,9-dien-11.beta.-yl)benzaldehyde-(1e or 1z)-oximes |
| 01/13/2010 | EP2142561A1 Process for preparing aromatase inhibitors |
| 01/12/2010 | CA2468412C 17.alpha.-alkyl-17.beta.-oxy-estratrienes and intermediates for their production, use of the 17.alpha.-alkyl-17.beta.-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations |
| 01/07/2010 | WO2009120678A3 Birch reduction of steroid substrates via alkali metal-silica gel materials |
| 12/31/2009 | US20090326251 Methods for preparing 17-alkynyl-7-hydroxy steroids and related compounds |
| 12/31/2009 | US20090325919 Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation |
| 12/31/2009 | US20090324489 Wortmannin conjugates and uses thereof |
| 12/30/2009 | EP1470151B1 Process for the preparation of 7-alpha-methylsteroids |
| 12/29/2009 | US7638509 Diene compounds and formulations |
| 12/29/2009 | US7638508 Glucocorticosteroid compound having anti-inflammatory activity |
| 12/24/2009 | US20090318721 Process for the preparation of 7alpha-alkylated 19-norsteroids |
| 12/23/2009 | EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy |
| 12/22/2009 | CA2585805C A process for the preparation of 17-hydroxy-6.beta.,7.beta.;15.beta., 16.beta.-bismethylene-17.alpha.-pregn-4-ene-3-one-21-carboxylic acid .gamma.-lactone and key-intermediates for this process |
| 12/17/2009 | US20090312293 process for the isolation of pharmacologically active principles of vegetable and animal origin |
| 12/10/2009 | US20090306417 Process for the preparation of 7alpha-alkylated 19-norsteroids |
| 12/10/2009 | US20090306031 5alpha-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR |
| 12/10/2009 | CA2726364A1 6-substituted estradiol derivatives and methods of use |
| 12/10/2009 | CA2724130A1 Methods for preparing 17-alkynyl-7-hydroxy steroids and related compounds |
| 12/09/2009 | CN100567488C Enhancement of virus-mediated DNA transfer |
| 12/09/2009 | CN100567320C Midbody of steroid, and application |
| 12/08/2009 | US7629334 Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) |
| 12/02/2009 | CN101595119A Crystalline forms of 11 beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17- hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one |
| 11/26/2009 | US20090291929 Steroids having a mixed androgenic and progestagenic profile |
| 11/25/2009 | CN101585862A Novel steroids |
| 11/18/2009 | CN100560201C Preparing technological process of steroid 6 methylene stereoselectivity hydrogenation reaction catalyst |
| 11/17/2009 | CA2402524C Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate |
| 11/12/2009 | WO2009137337A1 STEREOSELECTIVE SYNTHESIS OF 17-α -AND 17-β -ARYL STEROIDAL COMPOUNDS |
| 11/12/2009 | WO2009135449A1 LIGANDS OF ESTROGEN RECEPTORS α AND β, METHOD OF THEIR PREPARATION AND PHARMACEUTICALS COMPRISING THEM |
| 11/11/2009 | CN100558741C 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 11/10/2009 | CA2551737C Helix 12 directed steroidal pharmaceutical products |
| 11/10/2009 | CA2186953C Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding |
| 10/29/2009 | US20090270642 Preparation of bile acids and intermediates thereof |
| 10/28/2009 | CN101565442A Novel estrogenic compound, preparation method and application thereof |
| 10/27/2009 | CA2414584C 7-hydroxyepiandrosterone having neuroprotective activity |
| 10/20/2009 | CA2423454C Estrogen-linked platinum (ii) complexes as anticancer agents |
| 10/15/2009 | WO2009059765A3 Process for the preparation of drospirenone |
| 10/15/2009 | WO2009054725A3 Means and methods for counteracting muscle disorders |
| 10/13/2009 | US7601857 Preparation of 6-hydroxyequilenins |
| 10/08/2009 | US20090253922 Process for Production of Steroid Compound |
| 10/08/2009 | CA2728889A1 Solid state forms of a pharmaceutical |
| 10/01/2009 | WO2009120678A2 Birch reduction of steroid substrates via alkali metal-silica gel materials |
| 09/24/2009 | WO2009115060A1 5-FLUORO-3α,17β-DIHYDROXY-5α-ANDROSTAN-6-ONE, THE METHOD FOR ITS PRODUCTION AND ITS USE FOR INFLUENCING OF PLANT GROWTH |
| 09/23/2009 | CN101541823A Progesterone receptor antagonists |
| 09/23/2009 | CN101537344A Monolithic column, preparation method and application thereof |
| 09/17/2009 | WO2009093262A3 Process for preparing aromatase inhibitor exemestane |
| 09/16/2009 | EP2099460A2 6-alkoxyalkyl estradiol derivatives and methods of use |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/09/2009 | EP2097437A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 09/09/2009 | CN101525364A Crystal form of fulvestrant and preparation method thereof |
| 09/09/2009 | CN100536835C Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 08/27/2009 | US20090215737 Pharmaceutical Compositions - 2 |
| 08/26/2009 | EP1298115B1 Process for the preparation of polyhydric alcohols |
| 08/25/2009 | US7579334 Compounds with anti-inflammatory activity |
| 08/11/2009 | US7572781 Prodrugs for use as ophthalmic agents |
| 08/06/2009 | US20090197842 Therapeutic Agent for Neuropathic Pain |
| 08/05/2009 | EP2083621A2 Modulators of amyloid-beta production |
| 08/05/2009 | CN100522984C Steroid compounds having contraceptive and anti-osteoporosis activity |
| 08/04/2009 | CA2523369C Process for preparing guggulsterones and guggulsterol |
| 07/30/2009 | WO2009093262A2 Process for preparing aromatase inhibitor exemestane |
| 07/30/2009 | WO2009013310A3 Process for preparing 7-alpha-[9-(4,4,5,5,5-pentafluorothiopentyl)nonyl]estra-1,3,5(10)-triene-3,17-beta-diol |
| 07/29/2009 | EP2081951A1 Progesterone receptor antagonists |
| 07/29/2009 | EP1399221B1 Compositions comprising oestrone-3-o-sulphamate and trail (tnf-related apoptosis inducing ligand) |
| 07/29/2009 | CN101492487A Process to prepare eplerenone |
| 07/16/2009 | US20090181936 antiandrogen compounds, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal, and methods for their use in the prevention and treatment of conditions mediated by androgen receptors, such as prostrate cancer |
| 07/15/2009 | EP2078031A2 Monoesters of estrogens with conjugated linoleic acid and uses thereof |
| 07/15/2009 | EP1633771B1 Macrolide-conjugates with anti-inflammatory activity |
| 07/15/2009 | EP1370268B1 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 07/09/2009 | US20090176754 Crystalline Form of the Compound A-348441 |
| 07/09/2009 | US20090176752 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 07/08/2009 | EP1622926B1 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds |
| 07/02/2009 | US20090169484 Iron-salen complex |
| 07/01/2009 | CN101469013A Method for preparing rocuronium important intermediate |
| 06/30/2009 | US7553830 Compositions for the delivery of negatively charged molecules |
| 06/25/2009 | WO2009077454A1 Process for obtaining 6-alkylidenandrost-1, 4-diene-3-one |
| 06/25/2009 | US20090163458 Compositions and methods for treating Parkinson's disease and related disorders |
| 06/25/2009 | CA2708823A1 Process for obtaining 6-alkylidenandrost-1, 4-diene-3-one |
| 06/23/2009 | US7550451 Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy |
| 06/23/2009 | US7550450 Prostate cancer treatment |
| 06/18/2009 | CA2709156A1 Methods for detecting estrone by mass spectrometry |
| 06/17/2009 | EP2070943A1 Process for obtaining 6-Alkylidenandrost-1,4-diene-3one |
| 06/17/2009 | EP2070942A1 Method for aromatising 19-nor-androst-4-en-3-ones to estra-1,3,5(10)-trienes |
| 06/17/2009 | EP2070941A1 Stereoselective synthesis of selective estrogen receptor down-regulators |